title: Part Two: Against the motion. All TEVAR patients do not require lifelong follow-up by annual CTA/MRA.[Con].
authors.affiliation: Department of Vascular and Endovascular Surgery, Klinikum Nurnberg, Nurnberg, Germany.
authors.forename: A
authors.initials: A
authors.lastname: Katsargyris
authors.forename: E L G
authors.initials: EL
authors.lastname: Verhoeven
mesh_terms: D000367:Age Factors; D001013:Aorta, Thoracic / Q000000981:diagnostic imaging / Q000473:pathology / Q000601:surgery*; D001018:Aortic Diseases / Q000601:surgery*; D001027:Aortography / Q000009:adverse effects / Q000191:economics / Q000379:methods*; D001807:Blood Vessel Prosthesis; D019917:Blood Vessel Prosthesis Implantation / Q000009:adverse effects* / Q000295:instrumentation; D003362:Cost-Benefit Analysis; D057867:Endoleak / Q000175:diagnosis / Q000209:etiology; D057510:Endovascular Procedures / Q000009:adverse effects* / Q000295:instrumentation; D005548:Foreign-Body Migration / Q000175:diagnosis / Q000209:etiology; D006801:Humans; D018810:Magnetic Resonance Angiography / Q000009:adverse effects / Q000191:economics; D011159:Population Surveillance; D011237:Predictive Value of Tests; D011475:Prosthesis Failure; D015607:Stents; D013997:Time Factors; D014057:Tomography, X-Ray Computed / Q000009:adverse effects / Q000191:economics; D016896:Treatment Outcome